Market Cap 122.40B
Revenue (ttm) 402.07B
Net Income (ttm) 1.77B
EPS (ttm) N/A
PE Ratio 12.27
Forward PE 11.98
Profit Margin 0.44%
Debt to Equity Ratio 0.81
Volume 12,403,300
Avg Vol 8,323,588
Day's Range N/A - N/A
Shares Out 1.28B
Stochastic %K 13%
Beta 0.61
Analysts Strong Sell
Price Target $114.29

Company Profile

CVS Health Corporation provides health solutions in the United States. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services, including medical, pharmacy, dental, and behavioral health plans; medical management capabilities; Medicare Advantage and Medicare Supplement plans; prescription drug plans (PDPs); and Medicaid health care management services. It serves employer groups, individuals, college students, part-time...

Industry: Healthcare Plans
Sector: Healthcare
Phone: 401 765 1500
Fax: 401 652 0893
Address:
One CVS Drive, Woonsocket, United States
OnlyFibs
OnlyFibs Aug. 10 at 2:57 AM
$CVS is coiling tightly as heavy institutional call sweeps highlight accumulation right near key technical trendline support. Driven by steady retail pharmacy cash flows and strong long-term LEAPS positioning, the technical framework is primed for an orderly expansion back toward multi-month highs. Bull Key Levels: A confirmed break and hold above immediate horizontal resistance at $97.50 unlocks a fast track toward the $100.00 psychological barrier. 🐂 🚀 Bear Key Levels: Losing support at $92.00 shifts short-term control back to sellers and accelerates a retest of lower volume floors. 🐻 🛑 Take Profit Targets: $102.00 / $105.00. 💰 🎯 #hovdid #CVS #TechnicalAnalysis #PriceAction #Stocks
0 · Reply
BioTechHealthX
BioTechHealthX Aug. 9 at 2:46 AM
$CVS $JNJ $SYK $TMO $ABBV These undervalued healthcare stocks could deserve a closer look in 2026 as analysts highlight attractive valuations, GLP-1 growth, blockbuster drugs, medical technology and potential upside. https://biotechhealthx.com/biotech-news/top-10-healthcare-stocks-to-buy-with-1000-in-2026/
0 · Reply
snowflame_shot
snowflame_shot Aug. 8 at 11:44 PM
$CVS Would like to see $89.50 - $90 before hopping in.. but all depends if it rejects that support at that $93.89
0 · Reply
KathleenFinch1000
KathleenFinch1000 Aug. 8 at 4:43 PM
$CVS $SBUX $SPGI $NEM $HDB CVS continues integrating healthcare services, Starbucks focuses on improving store productivity, S&P Global benefits from financial-data and ratings demand, Newmont benefits from gold prices, and HDFC Bank benefits from India's structural financial growth. I'm watching same-store sales, credit conditions, and commodity prices.
0 · Reply
topstockalerts
topstockalerts Aug. 7 at 8:49 PM
Moody’s Ratings upgraded CVS Health’s outlook to positive from stable on Friday while affirming its Baa3 senior unsecured ratings, Ba1 junior subordinated ratings and Prime-3 commercial paper rating. The outlook revision reflects progress in CVS’s health insurance recovery, which has helped reduce financial leverage. The company has cut membership, adjusted pricing and benefit designs, and exited the individual health insurance market. Moody’s estimates CVS’s gross debt-to-EBITDA ratio at about 3.7x as of June 30, 2026, down from 5.0x at the end of 2024 and 4.4x at the end of 2025. Moody’s highlighted CVS’s scale and leading positions in pharmacy benefit management, retail pharmacy and health insurance, as well as favorable prescription-drug demand. A transition to a new pharmacy reimbursement model is also improving retail pharmacy performance. $CVS
0 · Reply
THE_TRADE
THE_TRADE Aug. 7 at 5:37 PM
1 · Reply
StockNavigator_
StockNavigator_ Aug. 7 at 3:30 PM
Joel Greenblatt’s Magic Formula investing list update 📊 (Part 1) Some notable names showing up on the list: 💰 $ADBE — FCF yield 10% 💰 $BMY — FCF yield 8.7% 💰 $CROX — FCF yield 11% 💰 $CVS — FCF yield 9.6% 💰 $DECK — FCF yield 8.4% What caught my attention is that many of these companies are not the market’s current favorites, but they’re trading at valuations where free cash flow is becoming harder to ignore. The Magic Formula approach focuses on finding quality businesses at attractive prices. It doesn’t mean every name will work immediately, but these are the types of setups worth keeping on the radar. The next move usually starts before everyone notices. Stay prepared, not reactive.
0 · Reply
THE_TRADE
THE_TRADE Aug. 7 at 3:17 PM
0 · Reply
THE_TRADE
THE_TRADE Aug. 7 at 3:17 PM
0 · Reply
THE_TRADE
THE_TRADE Aug. 7 at 3:16 PM
$CVS $DIA $XLV $SPY $BLK DA Davidson Adjusts Price Target on CVS Health to $120 From $100, Maintains Buy Rating | MarketScreener https://share.google/UUQomR1pQgl2XsZUt
0 · Reply
Latest News on CVS
CVS Health price target raised to $107 from $94 at Baird

2026-08-06T13:20:31.000Z - 3 days ago

CVS Health price target raised to $107 from $94 at Baird


CVS Health price target raised to $126 from $122 at UBS

2026-08-06T10:36:22.000Z - 3 days ago

CVS Health price target raised to $126 from $122 at UBS


CVS Health price target raised to $108 from $106 at Barclays

2026-08-06T09:20:49.000Z - 3 days ago

CVS Health price target raised to $108 from $106 at Barclays


CVS Health Earnings Call Transcript: Q2 2026

Aug 5, 2026, 8:00 AM EDT - 4 days ago

CVS Health Earnings Call Transcript: Q2 2026


CVS Health Quarterly report: Q2 2026

Aug 5, 2026, 8:00 AM EDT - 4 days ago

CVS Health Quarterly report: Q2 2026


CVS Health Slides: Q2 2026

Aug 5, 2026, 8:00 AM EDT - 4 days ago

CVS Health Slides: Q2 2026


CVS Health Earnings release: Q2 2026

Aug 5, 2026, 8:00 AM EDT - 4 days ago

CVS Health Earnings release: Q2 2026


CVS Health announces revamp of weight management program

2026-08-05T10:45:52.000Z - 4 days ago

CVS Health announces revamp of weight management program

LLY


CVS Health reports Q2 adjusted EPS $2.58, consensus $1.85

2026-08-05T10:36:30.000Z - 4 days ago

CVS Health reports Q2 adjusted EPS $2.58, consensus $1.85


CVS raises annual profit forecast on improved drug revenues

Aug 5, 2026, 6:32 AM EDT - 4 days ago

CVS raises annual profit forecast on improved drug revenues


CVS's Turnaround Faces Its Next Test

Aug 4, 2026, 4:32 PM EDT - 5 days ago

CVS's Turnaround Faces Its Next Test


The Big 3: GOOGL, SMCI, CVS

Jul 24, 2026, 1:00 PM EDT - 16 days ago

The Big 3: GOOGL, SMCI, CVS

GOOG GOOGL SMCI


CVS Health price target raised to $122 from $115 at UBS

2026-07-24T12:35:25.000Z - 16 days ago

CVS Health price target raised to $122 from $115 at UBS


CVS Health says pet medications now available at CVS Pharmacy

2026-07-21T13:06:11.000Z - 19 days ago

CVS Health says pet medications now available at CVS Pharmacy


Pet medications now available at CVS Pharmacy®

Jul 21, 2026, 9:00 AM EDT - 19 days ago

Pet medications now available at CVS Pharmacy®


CVS Health declares quarterly dividend

Jul 10, 2026, 9:48 AM EDT - 4 weeks ago

CVS Health declares quarterly dividend


The Big 3: CVS, SLV, PLTR

Jul 1, 2026, 1:00 PM EDT - 5 weeks ago

The Big 3: CVS, SLV, PLTR

PLTR SLV


CVS is Using Fluency to Close Enterprise AI Deployment Gap

Jun 11, 2026, 10:43 AM EDT - 2 months ago

CVS is Using Fluency to Close Enterprise AI Deployment Gap


H1 Receives $40M Investment in Round Led by CVS Health Ventures

May 28, 2026, 11:00 AM EDT - 2 months ago

H1 Receives $40M Investment in Round Led by CVS Health Ventures


CVS brings back coverage for Lilly's obesity drug Zepbound

May 28, 2026, 6:47 AM EDT - 2 months ago

CVS brings back coverage for Lilly's obesity drug Zepbound

LLY


Glenview Capital Issues Statement on CVS Health

May 21, 2026, 4:15 PM EDT - 2 months ago

Glenview Capital Issues Statement on CVS Health


The Big 3: NKE, CVS, CSCO

May 20, 2026, 1:00 PM EDT - 2 months ago

The Big 3: NKE, CVS, CSCO

CSCO NKE


OnlyFibs
OnlyFibs Aug. 10 at 2:57 AM
$CVS is coiling tightly as heavy institutional call sweeps highlight accumulation right near key technical trendline support. Driven by steady retail pharmacy cash flows and strong long-term LEAPS positioning, the technical framework is primed for an orderly expansion back toward multi-month highs. Bull Key Levels: A confirmed break and hold above immediate horizontal resistance at $97.50 unlocks a fast track toward the $100.00 psychological barrier. 🐂 🚀 Bear Key Levels: Losing support at $92.00 shifts short-term control back to sellers and accelerates a retest of lower volume floors. 🐻 🛑 Take Profit Targets: $102.00 / $105.00. 💰 🎯 #hovdid #CVS #TechnicalAnalysis #PriceAction #Stocks
0 · Reply
BioTechHealthX
BioTechHealthX Aug. 9 at 2:46 AM
$CVS $JNJ $SYK $TMO $ABBV These undervalued healthcare stocks could deserve a closer look in 2026 as analysts highlight attractive valuations, GLP-1 growth, blockbuster drugs, medical technology and potential upside. https://biotechhealthx.com/biotech-news/top-10-healthcare-stocks-to-buy-with-1000-in-2026/
0 · Reply
snowflame_shot
snowflame_shot Aug. 8 at 11:44 PM
$CVS Would like to see $89.50 - $90 before hopping in.. but all depends if it rejects that support at that $93.89
0 · Reply
KathleenFinch1000
KathleenFinch1000 Aug. 8 at 4:43 PM
$CVS $SBUX $SPGI $NEM $HDB CVS continues integrating healthcare services, Starbucks focuses on improving store productivity, S&P Global benefits from financial-data and ratings demand, Newmont benefits from gold prices, and HDFC Bank benefits from India's structural financial growth. I'm watching same-store sales, credit conditions, and commodity prices.
0 · Reply
topstockalerts
topstockalerts Aug. 7 at 8:49 PM
Moody’s Ratings upgraded CVS Health’s outlook to positive from stable on Friday while affirming its Baa3 senior unsecured ratings, Ba1 junior subordinated ratings and Prime-3 commercial paper rating. The outlook revision reflects progress in CVS’s health insurance recovery, which has helped reduce financial leverage. The company has cut membership, adjusted pricing and benefit designs, and exited the individual health insurance market. Moody’s estimates CVS’s gross debt-to-EBITDA ratio at about 3.7x as of June 30, 2026, down from 5.0x at the end of 2024 and 4.4x at the end of 2025. Moody’s highlighted CVS’s scale and leading positions in pharmacy benefit management, retail pharmacy and health insurance, as well as favorable prescription-drug demand. A transition to a new pharmacy reimbursement model is also improving retail pharmacy performance. $CVS
0 · Reply
THE_TRADE
THE_TRADE Aug. 7 at 5:37 PM
1 · Reply
StockNavigator_
StockNavigator_ Aug. 7 at 3:30 PM
Joel Greenblatt’s Magic Formula investing list update 📊 (Part 1) Some notable names showing up on the list: 💰 $ADBE — FCF yield 10% 💰 $BMY — FCF yield 8.7% 💰 $CROX — FCF yield 11% 💰 $CVS — FCF yield 9.6% 💰 $DECK — FCF yield 8.4% What caught my attention is that many of these companies are not the market’s current favorites, but they’re trading at valuations where free cash flow is becoming harder to ignore. The Magic Formula approach focuses on finding quality businesses at attractive prices. It doesn’t mean every name will work immediately, but these are the types of setups worth keeping on the radar. The next move usually starts before everyone notices. Stay prepared, not reactive.
0 · Reply
THE_TRADE
THE_TRADE Aug. 7 at 3:17 PM
0 · Reply
THE_TRADE
THE_TRADE Aug. 7 at 3:17 PM
0 · Reply
THE_TRADE
THE_TRADE Aug. 7 at 3:16 PM
$CVS $DIA $XLV $SPY $BLK DA Davidson Adjusts Price Target on CVS Health to $120 From $100, Maintains Buy Rating | MarketScreener https://share.google/UUQomR1pQgl2XsZUt
0 · Reply
THE_TRADE
THE_TRADE Aug. 7 at 3:15 PM
$CVS DA Davidson Adjusts Price Target on CVS Health to $120 From $100, Maintains Buy Rating | MarketScreener https://share.google/UUQomR1pQgl2XsZUt
0 · Reply
THE_TRADE
THE_TRADE Aug. 7 at 3:13 PM
$CVS Agree and I've been adding
0 · Reply
Muktar65
Muktar65 Aug. 7 at 1:34 PM
$CVS Hot News! DA Davidson analyst raised his price target on CVS to $120 from $100 and maintains his Buy rating
0 · Reply
Reanimated666
Reanimated666 Aug. 7 at 1:33 PM
$CVS Let’s stop being silly here
0 · Reply
HydrogenH2
HydrogenH2 Aug. 7 at 12:06 PM
$CVS When Cramer says "But" i'm adding !!! lol 🤪😜 Always do the "opposite" of this CNBC's clown !!
0 · Reply
asthew0rldturns
asthew0rldturns Aug. 7 at 10:55 AM
$CVS What am I missing here? I have no position currently, but should this not be comfortably above 100? If think at least 105 would be a decent place to be sitting.
2 · Reply
Cracker36
Cracker36 Aug. 6 at 8:02 PM
$CVS did I miss something??? just tripled up on this on looking for min 105
0 · Reply
HydrogenH2
HydrogenH2 Aug. 6 at 5:44 PM
$CVS I'm adding some shares !!
0 · Reply
THE_TRADE
THE_TRADE Aug. 6 at 4:27 PM
$CVS $DIA $XLV $SPY $BLK Barclays Adjusts Price Target on CVS Health to $108 From $106 | MarketScreener https://share.google/XDOEpIjZJMV6e5TZj
0 · Reply
THE_TRADE
THE_TRADE Aug. 6 at 4:13 PM
$CVS $DIA $XLV $SPY $BLK Barclays Adjusts Price Target on CVS Health to $108 From $106 | MarketScreener https://share.google/XDOEpIjZJMV6e5TZj
0 · Reply
THE_TRADE
THE_TRADE Aug. 6 at 4:13 PM
$CVS $DIA $XLV $SPY $BLK Barclays Adjusts Price Target on CVS Health to $108 From $106 | MarketScreener https://share.google/XDOEpIjZJMV6e5TZjBarclays Adjusts Price Target on CVS Health to $108 From $106 | MarketScreener https://share.google/XDOEpIjZJMV6e5TZj
0 · Reply
THE_TRADE
THE_TRADE Aug. 6 at 4:12 PM
$CVS $DIA $XLV $SPY $BLK UBS raises CVS Health stock price target to $126 on margin recovery By Investing.com https://share.google/WakbadKGCNda7i8bZ
0 · Reply